Central Retinal Vein Occlusion in patients with COVID-19 infection: A systematic review.
Irfan Ullah,Aruba Sohail,Mir Umer Farooq Alam Shah,Maman Khurshid,Mufaddal Najmuddin Diwan,Abdul Qadir,Muhammad Irfan +6 more
Reads0
Chats0
TLDR
In this paper, a systematic review summarizes the evidence on patients diagnosed with central retinal vein occlusion (CRVO) secondary to COVID-19 secondary infection, and highlights the importance of identifying CRVO as an important complication of infection.Abstract:
This systematic review summarizes the evidence on patients diagnosed with central retinal vein occlusion (CRVO) secondary to COVID-19. We searched PubMed and Google Scholar from its inception till June 2021. From an initial 55 publications, 10 studies provided specific information on COVID-19 patients with CRVO. Studies described 10 patients, 60% were male and the mean age was 39.3 ± 11.6 years. Blurred vision (40%) and decreased vision (50%) were the most common presenting complain. Symptom onset ranged from 5 days to 6 weeks after initial complaint of fever. Laboratory results showed elevated inflammatory markers and D-dimers in 60% of patients included in our review. Common treatment options were intravitreal anti-VEGF injections, steroids, and anticoagulants. Traditional co-morbidities like diabetes mellites, hypertension, and morbid obesity (hyperlipidemia) were observed in only 3/10 patients. The prognosis was excellent as all patients saw improvement in their condition. Our findings highlight the importance of identifying CRVO as an important complication of COVID-19 infection. Thus, physicians should not overlook the likelihood of CRVO in patients with COVID-19 infection and offer prompt treatment.read more
Citations
More filters
Journal ArticleDOI
COVID-19 associated vasculitis: A systematic review of case reports and case series
Ka Lai Clara Wong,Mir Umer Farooq Alam Shah,Maman Khurshid,Irfan Ullah,Muhammad Junaid Tahir,Zohaib Yousaf +5 more
TL;DR: In this paper , the authors conducted a systematic review analyzing the association of COVID-19 with vasculitis and found that Maculopapular, violaceous, papular and erythematous rash were common.
Journal ArticleDOI
Ocular and Systemic Complications of COVID-19: Impact on Patients and Healthcare
TL;DR: A mini-review summarizes the potential complications and treatments of the SARS-CoV-2 virus on the systemic and ocular health of patients, as well as the effects of delayed health care as discussed by the authors .
Journal ArticleDOI
Consecutive central and branch retinal vein occlusions in the same eye of a young healthy COVID-19 patient: A unique case report
TL;DR: In this paper , a 39-year-old woman with the diagnosis of COVID-19 infection for two weeks presented with a nonischemic central retinal vein occlusion (CRVO) in her right eye.
Journal ArticleDOI
Facial palsy as a manifestation of COVID‐19: A systematic review of cases
Aiman Khurshid,Maman Khurshid,Aruba Sohail,Imran Mansoor Raza,Muhammad Khubab Ahsan,Mir Umer Farooq Alam Shah,Anab Rehan Taseer,Abdulqadir J. Nashwan,Irfan Ullah +8 more
TL;DR: This article conducted a systematic review of all published cases of facial palsy post COVID-19 infection in an attempt to educate the general population and medical practitioners regarding the likely occurrence of facial pal palsy in COVID•19 patients, its detection, effective treatment plan, and prognosis of the condition.
Journal ArticleDOI
A Literature Review of Pathophysiology, Clinical Manifestations, Medications and Optimal Dosage, Outpatient, and Post-hospitalization Use of Anticoagulation in COVID-19 Patients
TL;DR: In this paper , the authors reviewed the literature to summarize and present the latest research about the pathophysiology, clinical manifestations, anticoagulation use and appropriate dose in COVID-19 patients.
References
More filters
Journal ArticleDOI
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page,Joanne E. McKenzie,Patrick M.M. Bossuyt,Isabelle Boutron,Tammy Hoffmann,Cynthia D. Mulrow,Larissa Shamseer,Jennifer Tetzlaff,Elie A. Akl,Sue E. Brennan,Roger Chou,Julie Glanville,Jeremy M. Grimshaw,Asbjørn Hróbjartsson,Manoj M. Lalu,Tianjing Li,Elizabeth Loder,Evan Mayo-Wilson,Steve McDonald,Luke A McGuinness,Lesley A. Stewart,James Thomas,Andrea C. Tricco,Vivian Welch,Penny Whiting,David Moher +25 more
TL;DR: The preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement as discussed by the authors was designed to help systematic reviewers transparently report why the review was done, what the authors did, and what they found.
Journal ArticleDOI
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta,Daniel F. McAuley,Michael Brown,Emilie Sanchez,Rachel Tattersall,Rachel Tattersall,Jessica J Manson +6 more
TL;DR: Re-analysis of data from a phase 3 randomised controlled trial of IL-1 blockade (anakinra) in sepsis, showed significant survival benefit in patients with hyperinflammation, without increased adverse events.
Journal ArticleDOI
Endothelial cell infection and endotheliitis in COVID-19.
Zsuzsanna Varga,Andreas J. Flammer,Peter Steiger,Martina Haberecker,Rea Andermatt,Annelies S. Zinkernagel,Mandeep R. Mehra,Reto A. Schuepbach,Frank Ruschitzka,Holger Moch +9 more
TL;DR: The vascular endothelium is an active paracrine, endocrine, and Endothelial cell infection and endotheliitis in COVID-19 and recruitment of immune cells can result in widespread endothelial dysfunction associated with apoptosis.
Journal ArticleDOI
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.
TL;DR: In the recent outbreak of novel coronavirus infection in Wuhan, China, significantly abnormal coagulation parameters in severe novel coronvirus pneumonia (NCP) cases were a concern.
Journal ArticleDOI
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
Beverley Shea,Beverley Shea,Barnaby C Reeves,George A. Wells,Micere Thuku,Candyce Hamel,Julian Moran,David Moher,David Moher,Peter Tugwell,Vivian Welch,Elizabeth Kristjansson,David Henry,David Henry +13 more
TL;DR: This paper reports on the updating of AMSTAR and its adaptation to enable more detailed assessment of systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both.